Skip to main content
logo
ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
11.26
-0.31 (-2.68%)
Sep 25, 2026, 3:28 PM EDT - Market open

ProMIS Neurosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
-35.66-33.38-10.64-7.88-16.09-4.63
Operating Income
-42.93-39.67-16.83-13.46-22.08-8.29
Net Income
-42.23-39.722.78-13.21-18.06-9.79
Earnings Per Share
-8.45-22.612.63-26.87-60.19-42.30
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
53.466.1513.3212.635.9216.98
Total Debt
-----3.91
Net Cash (Debt)
53.466.1513.3212.635.9213.08
Net Cash Growth
1076.78%-53.84%5.49%113.36%-54.73%1407.11%
Net Cash Per Share
10.703.5012.5925.6919.7356.51

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-42.11-28.12-27.18-10.84-17.03-9.31
Capital Expenditures
-----0-0.01
Free Cash Flow
-42.11-28.12-27.18-10.84-17.04-9.31
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--11.15---
PS Ratio
------